4National Cancer Institute (NCI).Common terminology criteria for adverse events v3. 0(CTCAE) [M].Washington:The Institute ;2006.
5Djordjevic J,Svorcan P,Vrinic D,et al.Splenomegaly and thrombocytopenia in patients with liver cirrhosis [J].Vojnosanit Pregl,2010;67(2):166-9.
6Zucker ML,Skikne BS,Rachel JM,et al.Mechanism of thrombocytopenia in hepatitis cas determined by the immature platelet fraction [J].Abstracts,2007; 110:3199.
7Pradella P,Bonetto S,Turchetto S,et al.Platelet production and destruction in liver cirrhosis[J].J Hepato1,2011 ;54(5):894-900.
8Taglieri N,Saia F,Rapezzi C,et al.Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome[J].Thromb Haemost,2011 ;106 (1):132-40.
9Kaito K,Otsubo H,Usui N,et al.Platelet size deviation width,platelet large cell ratio,and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia [J].Br J Haematol,2005 ; 128(5):698- 702.
